Phase II multicentre study of temozolomide in combination with interferon alpha-2b in metastatic malignant melanoma
Margarita García(American Society of Clinical Oncology), Josep Ramón Germà-Lluch(Hospital de Sant Pau), Julio Rifá(American Society of Clinical Oncology), Xavier García del Muro(Institut Català d'Oncologia), Xavier Pérez(Universitat Pompeu Fabra), Elena Filipovich(American Society of Clinical Oncology), A. Trés(Universidad de Zaragoza), Carmen Crespo(American Society of Clinical Oncology), Manuel Valladares(American Society of Clinical Oncology), Juan Lopez(American Society of Clinical Oncology)
Cited by 18
Related Papers
Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2018|1.6k
Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆
|Annals of Oncology|2021|978
Atezolizumab with or without chemotherapy in metastatic urothelial cancer (IMvigor130): a multicentre, randomised, placebo-controlled phase 3 trial
|The Lancet|2020|786